Multifunctional Theranostic Nanomedicines in Cancer focuses on new trends, applications, and the significance of novel multifunctional nanotheranostics in cancer imaging for diagnosis and treatment. Cancer nanotechnology offers new opportunities for cancer diagnosis and treatment. Multifunctional nanoparticles harboring various functions-including targeting, imaging, and therapy-have been intensively studied with the goal of overcoming the limitations of conventional cancer diagnosis and therapy. Thus theranostic nanomedicines have emerged in recent years to provide an efficient and safer alternative in cancer management. This book covers polymer-based therapies, lipid-based therapies, inorganic particle-based therapies, photo-related therapies, radiotherapies, chemotherapies, and surgeries. Multifunctional Theranostic Nanomedicines in Cancer offers an indispensable guide for researchers in academia, industry, and clinical settings; it is also ideal for postgraduate students; and formulation scientists working on cancer.

American manufacturing is on life support--at least, that's what most people think. The exodus of jobs to China and other foreign markets is irreversible, and anything that is built here requires specialized skills the average worker couldn't hope to gain. Not so, says Dan DiMicco, chairman and former CEO of Nucor, America's largest steel company. He not only revived a major US manufacturing firm during a recession, but helped galvanize the flagging domestic steel industry when many of his competitors were in bankruptcy or headed overseas. In American Made, he takes to task the politicians, academics, and political pundits who, he contends, are exacerbating fears and avoiding simple solutions for the sake of nothing more than their own careers, and contrasts them with the postwar leaders who rebuilt Europe and Japan, put a man on the moon, and kept communism at bay. We need leaders of such resolve today, he argues, who can tackle a broken job-creation engine by restoring manufacturing to its central role in the U.S. economy--and cease creating fictitious service businesses where jobs evaporate after a year or two, as in a Ponzi scheme. With his trademark bluntness, DiMicco tackles the false promise of green jobs and the hidden costs of outsourcing. Along the way, he shares the lessons he's learned about good leadership, crisis management, and the true meaning of innovation, and maps the road back to robust economic growth, middle-class prosperity, and American competitiveness.

Farmers markets are much more than places to buy produce. According to advocates for sustainable food systems, they are also places to "vote with your fork" for environmental protection, vibrant communities, and strong local economies. Farmers markets have become essential to the movement for food-system reform and are a shining example of a growing green economy where consumers can shop their way to social change.
"Black, White, and Green" brings new energy to this topic by exploring dimensions of race and class as they relate to farmers markets and the green economy. With a focus on two Bay Area markets--one in the primarily white neighborhood of North Berkeley, and the other in largely black West Oakland--Alison Hope Alkon investigates the possibilities for social and environmental change embodied by farmers markets and the green economy.
Drawing on ethnographic and historical sources, Alkon describes the meanings that farmers market managers, vendors, and consumers attribute to the buying and selling of local organic food, and the ways that those meanings are raced and classed. She mobilizes this research to understand how the green economy fosters visions of social change that are compatible with economic growth while marginalizing those that are not.
"Black, White, and Green" is one of the first books to carefully theorize the green economy, to examine the racial dynamics of food politics, and to approach issues of food access from an environmental-justice perspective. In a practical sense, Alkon offers an empathetic critique of a newly popular strategy for social change, highlighting both its strengths and limitations.

Tailor-Made Polysaccharides in Biomedical Applications provides extensive details on all the vital precepts, basics, and fundamental aspects of tailored polysaccharides in the pharmaceutical and biotechnological industries. This information provides readers with the foundation for understanding and developing high-quality products. The utilization of natural polymeric excipients in numerous healthcare applications demands the replacement of the synthetic polymers with natural polymers. Natural polymers are superior in terms of biocompatibility, biodegradability, economic extraction, and ready availability. Natural polymers are especially useful in that they are a renewable source of raw materials, as long as they are grown sustainably. Among these natural polymers, polysaccharides are considered as excellent excipients because they are nontoxic, stable, and biodegradable. Several research innovations have been carried out using polysaccharides in drug delivery applications. This book offers a comprehensive resource to understand the potential of these materials in forming new drug delivery methods. It will be useful to biomedical researchers, chemical engineers, regulatory scientists, and students who are actively involved in developing pharmaceutical products for biomedical applications by using tailor-made polysaccharides.

At present, human society is facing a health care crisis that is affecting patients worldwide. In the United States, it is generally believed that the major problem is lack of affordable access to health care (i.e. health insurance). This book takes an unprecedented approach to address this issue by proposing that the major problem is not lack of affordable access to health care per se, but lack of access to better, safer, and more affordable medicines. The latter problem is present not only in the United States and the developing world but also in countries with socialized health care systems, such as Europe and the rest of the industrialized world. This book provides a comparative analysis of the health care systems throughout the world and also examines the biotechnology and pharmaceutical industries.

Examines the health care structure of the United States, Europe, and the third world, both separately and comparativelyOffers primary source insight through in-depth interviews with pharmaceutical and health care industry leaders from around the worldCarefully explains, in clear terms, the intricacies of the health care and pharmaceutical system and how these intricacies have led to the current crisisOffers concrete, comprehensive solutions to the health care crisis

Written by a working CEO who increased earnings in some of the companies he led by 400 percent, this book provides a real-world prescription for prosperity and growth for any company, in any industry. For nearly two decades, America's industrial manufacturing sector has been in decline—and as a result, the nation's prosperity and strength is at risk. Meanwhile, China's manufacturing capabilities and competence continue to grow, threatening to overtake America as the world's most powerful and prosperous nation. Drawing on straightforward principles that can effectively be applied to a broad spectrum of manufacturing companies, author Steven L. Blue taps his leadership skills and proven processes honed over his career of growing companies—and saving them—to offer readers an inspiring vision for revitalizing the entire manufacturing sector. Using case studies and examples from his own experiences, both at Miller Ingenuity and in other roles earlier in his career, the author organizes his lessons in leadership, strategy, and change management into seven values of ingenuity: innovation, excellence, commitment, community, teamwork, respect, and integrity. The book explains how this highly integrated system of operating values can be implemented to turn around a company (if needed) or to propel it to extraordinary growth and prosperity.

In this book, leading experts in the field examine the effects of the recent growth in concentration in the European food retailing sector. In particular, the book develops a number of buyer power propositions and builds on the previous work of several of the authors, to consider how the growth of large supermarket chains affects competition in food retailing. The authors outline the theoretical and policy analysis underpinning the work and assess evidence on the size and growth of supermarket chains across the EU. Whilst not entirely critical, they suggest that there is strong evidence in some countries that supermarkets use their buying power to impose unfair terms and conditions on suppliers, particularly affecting small suppliers. The authors use case studies, to provide an in-depth analysis of four European countries, namely France, Germany, Spain and the UK. The book ends with a discussion of policy issues against a backdrop of likely future trends in concentration in this area. Academics working in the areas of microeconomics and industrial economics as well as those involved in European competition policy more generally, such as lawyers, civil servants and consultancy groups, will find this volume enlightening.

Over the past two decades, society has been witnessing how technological, political, and societal changes have been transforming individual and collective urban mobility. Driven both by newcomers and traditional players, by disruptive as well as incremental innovations, the main objective now is to enhance mobility and accessibility while, reducing vehicle ownership, congestion, road accidents, and pollution in cities. This transformation has been mainly enabled by the widespread adoption of internet-connected devices (e.g.: smartphones and tablets) and by the innovative business models, technologies, and use-cases that arose from this rapid digitalization, such as peer-to-peer, and two-sided markets providing several mobility schemes: car-sharing, car-pooling, bike sharing, free-floating (cars, bikes, electric scooter), ridesharing and ride hailing either for long distances as well as for urban and micro-mobility. The book presents - in a holistic perspective - how this revolution is happening and what are the major cornerstones for the implementation of robomobility. It aims at answering several substantial issues, such as: What is robomobility and what does it imply for the different stakeholders of the public transport ecosystem? How do policy makers integrate this innovation and how ready the regulations are? How do citizens take part in this transformation? What is the level of user acceptance for this new type of mobility? What are its environmental impacts? What is the economic impact of deploying these shuttles in a local ecosystem?

The Economics of Biotechnology is a highly accessible book dealing with some of the most crucial issues to arise in this area. Special attention is paid to consumer, ethical and environmental concerns as well as questions relating to trade policy, intellectual property, who will receive the benefits, international development and the role of international institutions such as the WTO. The authors examine concerns arising from the application of biotechnology in the agri-food industrial complex, and many of the issues discussed also have implications for the medical and pharmaceutical aspects of biotechnology. Fundamental questions regarding the application of standard economic analysis to biotechnology are resolved using traditional neo-classical analyses as well as less mainstream methods. Through exploring a number of approaches, original and unexpected conclusions are reached. This coherent and relevant treatment of the myriad facets of biotechnology will be welcomed by academics, scholars, and economists with a specific interest in international economics or technology, international policymakers, and economic commentators.

This book examines the manufacturing, supply chain and product-level sustainability of leather and footwear products. This book deals with the environmental and chemical sustainability aspects pertaining to the tanning supply chain and the related mitigation measures. The book also explores interesting areas of leather and footwear sustainability, such as waste & the 3R's and their certification for sustainability. At the product level, the book covers advanced topics like the circular economy and blockchain technology for leather and footwear products and addresses innovation development and eco-material use in footwear by investigating environmental sustainability and the use of bacterial cellulose, a potential sustainable alternative for footwear and leather products.

Japan has succeeded in many industries through its renowned production system. Competitive advantage, however, in the new economy is shifting from production to demand-based capabilities. One such new industry is pharmaceuticals, where Japan has been a resounding failure, both from public policy and corporate strategy perspectives. This book provides a detailed examination of how Japan has socially constructed its pharmaceutical industry, the economic and political bases of this construction and the consequences for corporate innovation and performance.Perhaps the starkest indication of this failure of Japanese public policy is the emergence of a new drug lag in that nation. Almost 90 percent of recent important new drugs are unavailable in Japan, despite their widespread diffusion throughout the rest of the world. Analysis of this drug lag confirms that it is not due to government discrimination against Western firms, but rather is only one of many consequences of failed Japanese industrial policies. The author presents an analysis of the nature, causes and consequences of the new drug lag in Japan. He contrasts the problem with the one experienced in the US and looks at the powerful role played by domestic politics in shaping the pharmaceutical industry. The last chapters look at the various remedies available. Academics, experts in government and industry, researchers and students of industrial policy, economics, public health and trade policy will find the examination of this important industry both informative and enlightening.

Preparation of Phytopharmaceuticals for the Management of Disorders: The Development of Nutraceuticals and Traditional Medicine presents comprehensive coverage and recent advances surrounding phytopharmaceuticals, nutraceuticals and traditional and alternative systems of medicines. Sections cover the concepts of phytopharmaceuticals, their history, and current highlights in phytomedicine. Also included are classifications of crude drugs, herbal remedies and toxicity, traditional and alternative systems of medicine, nanotechnology applications, and herbal cosmeticology. Final sections cover applications of microbiology and biotechnology in drug discovery. This book provides key information for everyone interested in drug discovery, including medicinal chemists, nutritionists, biochemists, toxicologists, drug developers and health care professionals. Students, professors and researchers working in the area of pharmaceutical sciences and beyond will also find the book useful.

Do environmental regulations harm international competitiveness? In answer to this question, this book focuses on the impact of regulatory policies on competitiveness and employment at the firm level. It investigates the trade-off between environmental regulations and competitiveness across countries and regions throughout Europe, using the food processing industry as a case study.The authors compare and contrast the experiences of similar firms across Europe to examine the different costs firms face in applying environmental regulations and the different levels of competitiveness they achieve as a result. The investigation includes a detailed and thorough comparison of the European food processing industries using 67 company case studies. The results show that firms can achieve national or international levels of competitiveness even when they face a relatively unfavourable level of regulatory costs. These important findings will almost certainly have general application to small and medium sized firms in other industries. This book will be welcomed by policymakers, practitioners, researchers and academics interested in industrial economics, environmental management and environmental economics.

Artificial Intelligence Medicine: Technical Basis and Clinical Applications presents a comprehensive overview of the field, ranging from its history and technical foundations, to specific clinical applications and finally to prospects. Artificial Intelligence (AI) is expanding across all domains at a breakneck speed. Medicine, with the availability of large multidimensional datasets, lends itself to strong potential advancement with the appropriate harnessing of AI. The integration of AI can occur throughout the continuum of medicine: from basic laboratory discovery to clinical application and healthcare delivery. Integrating AI within medicine has been met with both excitement and scepticism. By understanding how AI works, and developing an appreciation for both limitations and strengths, clinicians can harness its computational power to streamline workflow and improve patient care. It also provides the opportunity to improve upon research methodologies beyond what is currently available using traditional statistical approaches. On the other hand, computers scientists and data analysts can provide solutions, but often lack easy access to clinical insight that may help focus their efforts. This book provides vital background knowledge to help bring these two groups together, and to engage in more streamlined dialogue to yield productive collaborative solutions in the field of medicine.

Manufacturing has played a key role in the economic fortunes of the East and South Asian regions. This timely book analyses patterns of rapid catch-up and relative stagnation in the manufacturing sector and links these to economic growth in the region. Dr Timmer describes the manufacturing performance of five Asian countries since the 1960s: China, India, Indonesia, South Korea and Taiwan. Over this period Asian industrial development is placed in an international perspective by comparison with the world productivity leader, the USA. The author uses new empirical data to assess the degree of structural change in the manufacturing sector and its importance for productivity growth. He then discusses conditions for economic growth and catch up, and reviews the role of industrial and technology policies in the promotion of industrial development in Asia.

The Future of Pharmaceutical Product Development and Research examines the latest developments in the pharmaceutical sciences, also highlighting key developments, research and future opportunities. Written by experts in the field, this volume in the Advances in Pharmaceutical Product Development and Research series deepens our understanding of the product development phase of drug discovery and drug development. Each chapter covers fundamental principles, advanced methodologies and technologies employed by pharmaceutical scientists, researchers and the pharmaceutical industry. The book focuses on excipients, radiopharmaceuticals, and how manufacturing should be conducted in an environment that follows Good Manufacturing Practice (GMP) guidelines. Researchers and students will find this book to be a comprehensive resource for those working in, and studying, pharmaceuticals, cosmetics, biotechnology, foods and related industries.

This book aims to provide the reader with an understanding of the concept of the circular economy, in relation to food supply chains. The current food supply chain system, based upon the linear supply chain model, is unquestionably unsustainable: make, use, dispose. The circular supply chain model, on the other hand, aims to keep resources in use for as long as possible, while regenerating products/materials at the end of their service life. In short: reduce, reuse, recycle. This book puts forwards the circular economy as an alternative to the traditional supply chain management models. The circular economy aims to minimise material, energy and environmental damage without restricting economic growth and social and technological progress. It involves transition to renewable energy sources, and it builds on economic, natural and social capital. This shortform monograph will appeal to academics working in the fields of supply chain logistics, operation management, agricultural management, and sustainability more broadly. Dr. Stella Despoudi is Lecturer in Operations and Supply Chain Management at Aston University, UK and Adjunct Lecturer in Supply Chain Management at University of Western Macedonia, Greece. Prof. Uthayasankar Sivarajah is Head of School of Management and Professor of Technology Management and Circular Economy at the School of Management, University of Bradford, UK. Dr Manoj Dora is Director of Collaborative Projects and Outreach at Brunel Business School, UK. Manoj's areas of specialisation are Sustainable Value Chain and Quality Management, with a focus on Lean Six Sigma in the agro-food sector.